TWiV 1030: Clinical update with Dr. Daniel Griffin episode artwork

EPISODE · Jul 29, 2023 · 32 MIN

TWiV 1030: Clinical update with Dr. Daniel Griffin

from This Week in Virology · host VIncent Racaniello

In his weekly clinical update, Dr. Griffin discusses the use of RSV vaccines in older adults: recommendations of the advisory committee on immunization practices, case report of leprosy in Central Florida, blood group A enhances SARS-CoV-2 infection, predicting COVID-19 incidence using wastewater surveillance data, a common allele of HLA associated with asymptomatic SARS-CoV-2 infection, prevalence of low-frequency, antiviral resistance variants in SARS-CoV-2 isolates in Ontario, Canada, viral resistance analyses from the Remdesivir phase 3 adaptive COVID-19 treatment trial-1, impact of Molnupiravir treatment on patient-reported COVID-19 symptoms in the phase 3 move-out trial, Molnupiravir for treatment of adults with mild or moderate COVID-19, delayed intubation associated with in-hospital mortality in patients with COVID-19 respiratory failure who fail heated and humified high flow nasal canula, relationship between azithromycin and cardiovascular outcomes in unvaccinated patients with COVID‐19 and preexisting cardiovascular disease, and the effects of COVID-19 on cognitive performance in a community-based cohort, clinical phenotypes and quality of life to define post-COVID-19 syndrome. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Use of RSV vaccines in older adults (CDC) Case report of leprosy in Central Florida (EID) Blood group A enhances SARS-CoV-2 infection (Blood) Predicting COVID-19 incidence using wastewater surveillance data (EID) Common allele of HLA  associated with asymptomatic SARS-CoV-2 infection (Nature) Prevalence of low-frequency antiviral resistance variants in SARS-CoV-2 isolates (JAMA) Viral resistance analyses from the Remdesivir phase 3 treatment trial (JID) Impact of Molnupiravir treatment on patient-reported COVID-19 symptoms (CID) Molnupiravir for treatment of adults with mild or moderate COVID-19 (CMI) Delayed intubation associated with in-hospital mortality in patients with COVID-19 (BMC) Relationship between Azithromycin and cardiovascular outcomes in unvaccinated patients with COVID‐19 (JAHA) The effects of COVID-19 on cognitive performance in a community-based cohort (eClinical) Clinical phenotypes and quality of life to define post-COVID-19 syndrome (eClinical) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1030 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Episode metadata supplied by the publisher feed · Published Jul 29, 2023

Embed this episode

NOW PLAYING

TWiV 1030: Clinical update with Dr. Daniel Griffin

0:00 32:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Week in Virology?

This episode is 32 minutes long.

When was this This Week in Virology episode published?

This episode was published on July 29, 2023.

Can I download this This Week in Virology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!